Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice

Radiother Oncol. 2011 Oct;101(1):100-8. doi: 10.1016/j.radonc.2011.09.019. Epub 2011 Oct 14.

Abstract

Background and purpose: We previously showed that irradiating the carotid arteries of ApoE(-/-) mice accelerated the development of macrophage-rich, inflammatory and thrombotic atherosclerotic lesions. In this study we investigated the potential of anti-inflammatory (atorvastatin, CD40L knockout) and anti-thrombotic (clopidogrel) intervention strategies to inhibit radiation-induced atherosclerosis.

Material and methods: ApoE(-/-) mice were given 0 or 14 Gy to the neck and the carotid arteries were harvested at 4 or 28 weeks after irradiation. Atorvastatin (15 mg/kg/day) or clopidogrel (20 mg/kg/day) was given in the chow; control groups received regular chow. Clopidogrel inhibited platelet aggregation by 50%. CD40L(-/-)/ApoE(-/-) and ApoE(-/-) littermates were also given 0 or 14 Gy to the neck and the carotid arteries were harvested after 30 weeks.

Results: Clopidogrel decreased MCP-1 expression in the carotid artery at 4 weeks after irradiation. Expression of VCAM-1, ICAM-1, thrombomodulin, tissue factor and eNOS was unchanged in atorvastatin and clopidogrel-treated mice. Neither drug inhibited either age-related or radiation-induced atherosclerosis. Furthermore, loss of the inflammatory mediator CD40L did not influence the development of age-related and radiation-induced atherosclerosis.

Conclusions: The effects of radiation-induced atherosclerosis could not be circumvented by these specific anti-inflammatory and anti-coagulant therapies. This suggests that more effective drug combinations may be required to overcome the radiation stimulus, or that other underlying mechanistic pathways are involved compared to age-related atherosclerosis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Apolipoproteins E / deficiency*
  • Apolipoproteins E / metabolism
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / etiology*
  • Atherosclerosis / pathology
  • Atorvastatin
  • CD40 Antigens / radiation effects
  • Carotid Arteries / pathology
  • Carotid Arteries / radiation effects
  • Clopidogrel
  • Disease Models, Animal
  • Heptanoic Acids / pharmacology*
  • Immunohistochemistry
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Platelet Aggregation Inhibitors / pharmacology
  • Pyrroles / pharmacology*
  • Radiation Dosage
  • Radiation Injuries, Experimental / complications*
  • Random Allocation
  • Reference Values
  • Statistics, Nonparametric
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Apolipoproteins E
  • CD40 Antigens
  • Heptanoic Acids
  • Platelet Aggregation Inhibitors
  • Pyrroles
  • Atorvastatin
  • Clopidogrel
  • Ticlopidine